KONINKLIJKE PHILIPS N.V. (PHG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Feb 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PHG SEC filings page.
KONINKLIJKE PHILIPS N.V. (PHG) reported $20.9B in revenue for fiscal year 2025, up 12.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of KONINKLIJKE PHILIPS N.V.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
KONINKLIJKE PHILIPS N.V. has an operating margin of 8.0%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 35/100, indicating healthy but not exceptional operating efficiency. This is up from 2.9% the prior year.
KONINKLIJKE PHILIPS N.V.'s revenue grew 12.2% year-over-year to $20.9B, a solid pace of expansion. This earns a growth score of 38/100.
KONINKLIJKE PHILIPS N.V. has a moderate D/E ratio of 0.63. This balance of debt and equity financing earns a leverage score of 35/100.
KONINKLIJKE PHILIPS N.V.'s current ratio of 1.32 indicates adequate short-term liquidity, earning a score of 35/100. The company can meet its near-term obligations, though with limited headroom.
Not available for KONINKLIJKE PHILIPS N.V., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.
KONINKLIJKE PHILIPS N.V.'s ROE of 8.2% shows moderate profitability relative to equity, earning a score of 34/100. This is up from -5.9% the prior year.
KONINKLIJKE PHILIPS N.V. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 2 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
KONINKLIJKE PHILIPS N.V. earns $4.94 in operating income for every $1 of interest expense ($1.7B vs $338.0M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.
Key Financial Metrics
Earnings & Revenue
KONINKLIJKE PHILIPS N.V. generated $20.9B in revenue in fiscal year 2025. This represents an increase of 12.2% from the prior year.
KONINKLIJKE PHILIPS N.V.'s EBITDA was $3.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 50.6% from the prior year.
KONINKLIJKE PHILIPS N.V. reported $1.1B in net income in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
KONINKLIJKE PHILIPS N.V. earned $1.09 per diluted share (EPS) in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.
Cash & Balance Sheet
KONINKLIJKE PHILIPS N.V. held $3.3B in cash against $8.1B in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
KONINKLIJKE PHILIPS N.V.'s gross margin was 45.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.0 percentage points from the prior year.
KONINKLIJKE PHILIPS N.V.'s operating margin was 8.0% in fiscal year 2025, reflecting core business profitability. This is up 5.0 percentage points from the prior year.
KONINKLIJKE PHILIPS N.V.'s net profit margin was 5.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 8.9 percentage points from the prior year.
KONINKLIJKE PHILIPS N.V.'s ROE was 8.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.0 percentage points from the prior year.
Capital Allocation
KONINKLIJKE PHILIPS N.V. invested $2.0B in research and development in fiscal year 2025. This represents an increase of 10.3% from the prior year.
KONINKLIJKE PHILIPS N.V. invested $315.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 3.8% from the prior year.
Not reported for fiscal year 2025.
PHG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.9B+12.2% | $18.7B-7.2% | $20.1B+5.4% | $19.1B-1.8% | $19.4B-8.3% | $21.2B+10.0% | $19.3B-7.3% | $20.8B-2.9% | $21.4B+16.3% | $18.4B+0.7% | $18.2B |
| Cost of Revenue | $11.5B+8.2% | $10.6B-10.6% | $11.9B+4.3% | $11.4B+0.6% | $11.3B-2.6% | $11.6B+11.8% | $10.4B-5.3% | $11.0B-5.0% | $11.5B+15.3% | $10.0B-3.9% | $10.4B |
| Gross Profit | $9.5B+17.5% | $8.0B-2.3% | $8.2B+7.1% | $7.7B-5.1% | $8.1B-15.2% | $9.6B+7.8% | $8.9B-9.5% | $9.8B-0.4% | $9.8B+17.4% | $8.4B+7.0% | $7.8B |
| R&D Expenses | $2.0B+10.3% | $1.8B-13.5% | $2.1B-6.5% | $2.2B+9.4% | $2.0B-8.3% | $2.2B+10.9% | $2.0B-0.3% | $2.0B-5.0% | $2.1B+20.4% | $1.8B+3.8% | $1.7B |
| Operating Income | $1.7B+205.2% | $547.6Mn/m | -$127.2Mn/m | -$1.6B-361.3% | $625.9M-59.5% | $1.5B+0.8% | $1.5B-22.1% | $2.0B+8.0% | $1.8B+18.1% | $1.5B+116.2% | $714.5M |
| EBITDA | $3.0B+50.6% | $2.0B+56.7% | $1.3B+1523.3% | $78.1M-96.3% | $2.1B-36.3% | $3.3B+9.6% | $3.0B-5.5% | $3.2B+5.3% | $3.1B+18.7% | $2.6B+45.5% | $1.8B |
| Interest Expense | $338.0M+13.4% | $298.1M-2.7% | $306.4M+21.9% | $251.4M+39.7% | $180.0M-14.9% | $211.6M-3.8% | $220.0M+2.2% | $215.4M-19.3% | $266.9M-26.0% | $360.9M-3.4% | $373.5M |
| Income Tax | $331.0M-66.8% | $996.8Mn/m | -$80.8Mn/m | -$120.9Mn/m | -$116.6M-145.0% | $259.3M-10.5% | $289.7M+31.0% | $221.1M-47.3% | $419.6M+95.9% | $214.2M+16.7% | $183.5M |
| Net Income | $1.1Bn/m | -$726.6Mn/m | -$515.5Mn/m | -$1.7B-145.8% | $3.8B+158.8% | $1.5B+10.8% | $1.3B+4.9% | $1.2B-37.3% | $2.0B+30.4% | $1.5B+125.5% | $677.6M |
| EPS (Basic) | $1.10n/m | -$0.78n/m | -$0.54n/m | -$1.81-145.4% | $3.98+148.7% | $1.60+12.4% | $1.43+7.3% | $1.33-37.9% | $2.14+28.4% | $1.67+125.8% | $0.74 |
| EPS (Diluted) | $1.09n/m | -$0.78n/m | -$0.54n/m | -$1.81-145.6% | $3.96+151.1% | $1.58+12.4% | $1.40+7.5% | $1.31-37.9% | $2.10+27.8% | $1.65+122.9% | $0.74 |
| Diluted Shares (Avg) | 963M+3.1% | 933M-1.6% | 948M-0.4% | 952M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: SG&A Expenses.
PHG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.6B+5.4% | $30.0B-7.8% | $32.5B-0.9% | $32.8B-6.3% | $35.0B+3.4% | $33.9B+11.7% | $30.3B+1.8% | $29.8B-2.1% | $30.4B-10.6% | $34.1B | N/A |
| Current Assets | $11.7B+12.4% | $10.4B-5.7% | $11.0B+0.2% | $11.0B-6.3% | $11.7B-14.7% | $13.7B+29.3% | $10.6B-3.2% | $11.0B-9.8% | $12.2B-18.1% | $14.9B | N/A |
| Cash & Equivalents | $3.3B+31.9% | $2.5B+20.2% | $2.1B+64.9% | $1.3B-51.9% | $2.6B-33.9% | $3.9B+146.6% | $1.6B-17.3% | $1.9B-17.0% | $2.3B-5.4% | $2.5B+28.4% | $1.9B |
| Inventory | $3.4B+1.8% | $3.3B-14.3% | $3.9B-10.8% | $4.3B+10.9% | $3.9B+6.7% | $3.7B+17.6% | $3.1B+1.6% | $3.1B+8.3% | $2.8B-21.0% | $3.6B | N/A |
| Accounts Receivable | $4.1B+9.0% | $3.8B-8.0% | $4.1B-6.2% | $4.4B+2.7% | $4.3B-15.7% | $5.1B-0.6% | $5.1B+10.6% | $4.6B-1.6% | $4.7B-16.4% | $5.6B | N/A |
| Goodwill | $10.9B+1.2% | $10.7B-1.6% | $10.9B-0.3% | $11.0B-9.0% | $12.0B+22.8% | $9.8B+0.9% | $9.7B-0.3% | $9.7B+4.8% | $9.3B-1.0% | $9.4B | N/A |
| Total Liabilities | $18.7B+6.8% | $17.5B-8.7% | $19.2B+2.8% | $18.7B-0.2% | $18.7B-3.5% | $19.4B+19.7% | $16.2B+1.4% | $16.0B-0.3% | $16.0B-23.1% | $20.8B | N/A |
| Current Liabilities | $8.8B+4.5% | $8.4B-8.0% | $9.2B+8.0% | $8.5B+0.7% | $8.4B-10.9% | $9.5B+20.8% | $7.8B-13.9% | $9.1B+10.2% | $8.3B-25.3% | $11.1B | N/A |
| Non-Current Liabilities | $9.9B+9.0% | $9.1B-9.2% | $10.0B-1.1% | $10.1B-0.9% | $10.2B+3.5% | $9.9B+18.7% | $8.3B+21.9% | $6.8B-11.6% | $7.7B-12.3% | $8.8B | N/A |
| Long-Term Debt | $8.1B+10.5% | $7.4B-5.4% | $7.8B+0.1% | $7.8B+6.1% | $7.3B+5.0% | $7.0B+25.8% | $5.5B+41.2% | $3.9B-19.2% | $4.9B+14.6% | $4.2B-4.6% | $4.4B |
| Total Equity | $12.9B+3.5% | $12.4B-6.6% | $13.3B-6.1% | $14.2B-13.3% | $16.3B+12.6% | $14.5B+2.6% | $14.1B+2.1% | $13.8B-4.0% | $14.4B+9.0% | $13.2B+5.0% | $12.6B |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $9.5B-8.1% | $10.3B | N/A | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
PHG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation & Amortization | $1.3B-8.2% | $1.4B+3.1% | $1.4B-18.6% | $1.7B+14.5% | $1.5B-16.3% | $1.8B+18.6% | $1.5B+20.9% | $1.2B+1.2% | $1.2B+19.7% | $1.0B-2.4% | $1.1B |
| Capital Expenditures | $315.7M-3.8% | $328.1M-14.0% | $381.6M-19.7% | $475.0M+5.7% | $449.3M-24.2% | $593.2M+8.7% | $545.6M+12.9% | $483.4M-4.3% | $504.9M+32.9% | -$379.9M-19.0% | -$469.1M |
| Dividends Paid | $384.9M+37088.8% | $1.0M-53.2% | $2.2M-99.5% | $440.8M-19.2% | $545.5M+44505.7% | $1.2M-99.8% | $508.6M+10.7% | $459.4M-0.5% | $461.6M+32.6% | $348.2M+7.6% | $323.6M |
| Share Buybacks | N/A | $62.1Mn/m | $0-100.0% | $25.7M-97.0% | $856.8M+438.9% | $159.0M-77.2% | $697.2M+18.4% | $588.8M+54.0% | $382.3M-38.5% | -$621.5M+12.9% | -$550.6M |
Not reported in any period shown, so not listed: Operating Cash Flow, Stock-Based Compensation, Free Cash Flow, Investing Cash Flow, Financing Cash Flow.
PHG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.2%+2.0pp | 43.1%+2.1pp | 41.0%+0.6pp | 40.4%-1.4pp | 41.8%-3.4pp | 45.2%-0.9pp | 46.1%-1.1pp | 47.2%+1.2pp | 46.0%+0.4pp | 45.6%+2.7pp | 42.9% |
| Operating Margin | 8.0%+5.0pp | 2.9%+3.6pp | -0.6%+8.0pp | -8.6%-11.8pp | 3.2%-4.1pp | 7.3%-0.7pp | 8.0%-1.5pp | 9.5%+1.0pp | 8.5%+0.1pp | 8.4%+4.5pp | 3.9% |
| Net Margin | 5.0%+8.9pp | -3.9%-1.3pp | -2.6%+6.5pp | -9.0%-28.4pp | 19.4%+12.5pp | 6.9%+0.1pp | 6.8%+0.8pp | 6.0%-3.3pp | 9.3%+1.0pp | 8.3%+4.6pp | 3.7% |
| Return on Equity | 8.2%+14.0pp | -5.9%-2.0pp | -3.9%+8.3pp | -12.1%-35.1pp | 23.0%+13.0pp | 10.0%+0.7pp | 9.3%+0.2pp | 9.0%-4.8pp | 13.8%+2.3pp | 11.5%+6.2pp | 5.4% |
| Return on Assets | 3.3%+5.7pp | -2.4%-0.8pp | -1.6%+3.7pp | -5.2%-16.0pp | 10.7%+6.4pp | 4.3%0.0pp | 4.3%+0.1pp | 4.2%-2.4pp | 6.6%+2.1pp | 4.5% | N/A |
| Current Ratio | 1.32+0.1x | 1.230.0x | 1.20-0.1x | 1.29-0.1x | 1.39-0.1x | 1.45+0.1x | 1.36+0.2x | 1.21-0.3x | 1.47+0.1x | 1.34 | N/A |
| Debt-to-Equity | 0.630.0x | 0.590.0x | 0.580.0x | 0.55+0.1x | 0.450.0x | 0.48+0.1x | 0.39+0.1x | 0.28-0.1x | 0.340.0x | 0.320.0x | 0.35 |
| Liabilities-to-Equity | 1.460.0x | 1.410.0x | 1.44+0.1x | 1.32+0.2x | 1.14-0.2x | 1.33+0.2x | 1.140.0x | 1.150.0x | 1.11-0.5x | 1.57 | N/A |
| Asset Turnover | 0.660.0x | 0.620.0x | 0.620.0x | 0.580.0x | 0.55-0.1x | 0.620.0x | 0.63-0.1x | 0.700.0x | 0.70+0.2x | 0.54 | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. PHG | FY2025 | $20.9B | $1.1B | 5.0% | $26.3B | 35/100 |
| STERIS plc STE | FY2026 | $5.9B | $782.3M | 13.2% | $22.6B | 66/100 |
| DexCom, Inc. DXCM | FY2025 | $4.7B | $836.3M | 17.9% | $29.4B | 74/100 |
| Insulet Corporation PODD | FY2025 | $2.7B | $247.1M | 9.1% | $10.3B | 74/100 |
| Zimmer Biomet Holdings, Inc. ZBH | FY2025 | $8.2B | $705.1M | 8.6% | $18.8B | 59/100 |
| Smith & Nephew plc SNN | FY2025 | $6.2B | $625.0M | 10.1% | $12.9B | 59/100 |
Where KONINKLIJKE PHILIPS N.V. Ranks
Frequently Asked Questions
What is KONINKLIJKE PHILIPS N.V.'s annual revenue?
KONINKLIJKE PHILIPS N.V. (PHG) reported $20.9B in total revenue for fiscal year 2025. This represents a 12.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is KONINKLIJKE PHILIPS N.V.'s revenue growing?
KONINKLIJKE PHILIPS N.V. (PHG) revenue grew by 12.2% year-over-year, from $18.7B to $20.9B in fiscal year 2025.
Is KONINKLIJKE PHILIPS N.V. profitable?
Yes, KONINKLIJKE PHILIPS N.V. (PHG) reported a net income of $1.1B in fiscal year 2025, with a net profit margin of 5.0%.
What is KONINKLIJKE PHILIPS N.V.'s EBITDA?
KONINKLIJKE PHILIPS N.V. (PHG) had EBITDA of $3.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does KONINKLIJKE PHILIPS N.V. have?
As of fiscal year 2025, KONINKLIJKE PHILIPS N.V. (PHG) had $3.3B in cash and equivalents against $8.1B in long-term debt.
What is KONINKLIJKE PHILIPS N.V.'s gross margin?
KONINKLIJKE PHILIPS N.V. (PHG) had a gross margin of 45.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is KONINKLIJKE PHILIPS N.V.'s operating margin?
KONINKLIJKE PHILIPS N.V. (PHG) had an operating margin of 8.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is KONINKLIJKE PHILIPS N.V.'s net profit margin?
KONINKLIJKE PHILIPS N.V. (PHG) had a net profit margin of 5.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is KONINKLIJKE PHILIPS N.V.'s return on equity (ROE)?
KONINKLIJKE PHILIPS N.V. (PHG) has a return on equity of 8.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What are KONINKLIJKE PHILIPS N.V.'s total assets?
KONINKLIJKE PHILIPS N.V. (PHG) had $31.6B in total assets as of fiscal year 2025, including both current and long-term assets.
What are KONINKLIJKE PHILIPS N.V.'s capital expenditures?
KONINKLIJKE PHILIPS N.V. (PHG) invested $315.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does KONINKLIJKE PHILIPS N.V. spend on research and development?
KONINKLIJKE PHILIPS N.V. (PHG) invested $2.0B in research and development during fiscal year 2025.
What is KONINKLIJKE PHILIPS N.V.'s current ratio?
KONINKLIJKE PHILIPS N.V. (PHG) had a current ratio of 1.32 as of fiscal year 2025, which is considered adequate.
What is KONINKLIJKE PHILIPS N.V.'s debt-to-equity ratio?
KONINKLIJKE PHILIPS N.V. (PHG) had a debt-to-equity ratio of 0.63 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is KONINKLIJKE PHILIPS N.V.'s liabilities-to-equity ratio?
KONINKLIJKE PHILIPS N.V. (PHG) had a liabilities-to-equity ratio of 1.46 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is KONINKLIJKE PHILIPS N.V.'s return on assets (ROA)?
KONINKLIJKE PHILIPS N.V. (PHG) had a return on assets of 3.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is KONINKLIJKE PHILIPS N.V.'s P/E ratio?
KONINKLIJKE PHILIPS N.V. (PHG) trades at 25.0x earnings, its market capitalization divided by $1.1B net income, FY2025. The market capitalization is $26.3B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is KONINKLIJKE PHILIPS N.V.'s price-to-sales ratio?
KONINKLIJKE PHILIPS N.V. (PHG) trades at 1.3x sales, its market capitalization divided by $20.9B revenue, FY2025. The market capitalization is $26.3B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is KONINKLIJKE PHILIPS N.V.'s Piotroski F-Score?
KONINKLIJKE PHILIPS N.V. (PHG) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Can KONINKLIJKE PHILIPS N.V. cover its interest payments?
KONINKLIJKE PHILIPS N.V. (PHG) has an interest coverage ratio of 4.94x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is KONINKLIJKE PHILIPS N.V.?
KONINKLIJKE PHILIPS N.V. (PHG) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For KONINKLIJKE PHILIPS N.V. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.